Gilead Sciences Inc insider trading
GILDfinancial statementsForm 4 filings on EDGAR305 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at Gilead Sciences Inc bought $0 of stock in the open market, and 5 sold $14M. Officers and directors accounted for $0 of purchases and $14M of sales. The last reported transaction was an open-market sale by Dickinson Andrew D on October 15, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 16, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $14MAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
305 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Dickinson Andrew D | Chief Financial Officer | open-market sale10b5-1 | 3,000 | $156.22 | $469K | 161,096 | Oct 16, 2026 |
| Oct 15, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | open-market sale10b5-1 | 3,000 | $156.22 | $469K | 113,684 | Oct 16, 2026 |
| Oct 1, 2026 | O'Day Daniel Patrick | Chairman & CEO, Director | open-market sale10b5-1 | 12,000 | $147.72 | $2M | 569,683 | Oct 2, 2026 |
| Oct 1, 2026 | O'Day Daniel Patrick | Chairman & CEO, Director | open-market sale10b5-1 | 3,000 | $148.63 | $446K | 566,683 | Oct 2, 2026 |
| Sep 22, 2026 | Burkhart Erin | SVP, Controllership | option exercise | 2,223 | — | — | 2,223 | Sep 23, 2026 |
| Sep 22, 2026 | Burkhart Erin | SVP, Controllership | tax withholding | 768 | $152.67 | $117K | 1,455 | Sep 23, 2026 |
| Sep 15, 2026 | Dickinson Andrew D | Chief Financial Officer | open-market sale10b5-1 | 3,000 | $145.29 | $436K | 164,096 | Sep 16, 2026 |
| Sep 15, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | open-market sale10b5-1 | 1,600 | $143.69 | $230K | 118,084 | Sep 16, 2026 |
| Sep 15, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | open-market sale10b5-1 | 800 | $144.46 | $116K | 117,284 | Sep 16, 2026 |
| Sep 15, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | open-market sale10b5-1 | 600 | $145.29 | $87K | 116,684 | Sep 16, 2026 |
| Sep 10, 2026 | Dickinson Andrew D | Chief Financial Officer | option exercise | 2,797 | — | — | 168,443 | Sep 11, 2026 |
| Sep 10, 2026 | Dickinson Andrew D | Chief Financial Officer | tax withholding | 1,347 | $144.81 | $195K | 167,096 | Sep 11, 2026 |
| Sep 10, 2026 | Berger Dietmar | Chief Medical Officer | option exercise | 533 | — | — | 19,785 | Sep 11, 2026 |
| Sep 10, 2026 | Berger Dietmar | Chief Medical Officer | tax withholding | 263 | $144.81 | $38K | 19,522 | Sep 11, 2026 |
| Sep 10, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | option exercise | 2,797 | — | — | 121,031 | Sep 11, 2026 |
| Sep 10, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | tax withholding | 1,347 | $144.81 | $195K | 119,684 | Sep 11, 2026 |
| Sep 10, 2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | option exercise | 590 | — | — | 9,044 | Sep 11, 2026 |
| Sep 10, 2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | tax withholding | 285 | $144.81 | $41K | 8,759 | Sep 11, 2026 |
| Sep 10, 2026 | O'Day Daniel Patrick | Chairman & CEO, Director | option exercise | 8,780 | — | — | 585,913 | Sep 11, 2026 |
| Sep 10, 2026 | O'Day Daniel Patrick | Chairman & CEO, Director | tax withholding | 4,230 | $144.81 | $613K | 581,683 | Sep 11, 2026 |
| Sep 1, 2026 | O'Day Daniel Patrick | Chairman & CEO, Director | open-market sale10b5-1 | 1,600 | $147.51 | $236K | 590,533 | Sep 2, 2026 |
| Sep 1, 2026 | O'Day Daniel Patrick | Chairman & CEO, Director | open-market sale10b5-1 | 7,992 | $148.36 | $1M | 582,541 | Sep 2, 2026 |
| Sep 1, 2026 | O'Day Daniel Patrick | Chairman & CEO, Director | open-market sale10b5-1 | 5,408 | $149.38 | $808K | 577,133 | Sep 2, 2026 |
| Aug 26, 2026 | Welters Anthony | Director | option exercise | 7,718 | $60.67 | $468K | 20,612 | Aug 27, 2026 |
| Aug 26, 2026 | Welters Anthony | Director | open-market sale10b5-1 | 3,118 | $148.31 | $462K | 17,494 | Aug 27, 2026 |
| Aug 26, 2026 | Welters Anthony | Director | open-market sale10b5-1 | 4,600 | $148.82 | $685K | 12,894 | Aug 27, 2026 |
| Aug 26, 2026 | Welters Anthony | Director | option exercise | 10,282 | $61.35 | $631K | 23,176 | Aug 27, 2026 |
| Aug 26, 2026 | Welters Anthony | Director | open-market sale10b5-1 | 3,402 | $148.24 | $504K | 19,774 | Aug 27, 2026 |
| Aug 26, 2026 | Welters Anthony | Director | open-market sale10b5-1 | 6,880 | $148.82 | $1M | 12,894 | Aug 27, 2026 |
| Aug 20, 2026 | Bluestone Jeffrey | Director | option exercise | 1,165 | $67.45 | $79K | 11,231 | Aug 21, 2026 |
| Aug 20, 2026 | Bluestone Jeffrey | Director | open-market sale10b5-1 | 1,165 | $143.75 | $167K | 10,066 | Aug 21, 2026 |
| Aug 20, 2026 | Bluestone Jeffrey | Director | option exercise | 1,816 | $67.45 | $122K | 11,882 | Aug 21, 2026 |
| Aug 20, 2026 | Bluestone Jeffrey | Director | open-market sale10b5-1 | 1,816 | $144.92 | $263K | 10,066 | Aug 21, 2026 |
| Aug 20, 2026 | Bluestone Jeffrey | Director | option exercise | 1,658 | $67.45 | $112K | 11,724 | Aug 21, 2026 |
| Aug 20, 2026 | Bluestone Jeffrey | Director | open-market sale10b5-1 | 1,658 | $145.73 | $242K | 10,066 | Aug 21, 2026 |
| Aug 20, 2026 | Bluestone Jeffrey | Director | option exercise | 26 | $67.45 | $2K | 10,092 | Aug 21, 2026 |
| Aug 20, 2026 | Bluestone Jeffrey | Director | open-market sale10b5-1 | 26 | $146.36 | $4K | 10,066 | Aug 21, 2026 |
| Aug 20, 2026 | Bluestone Jeffrey | Director | option exercise | 335 | $61.35 | $21K | 10,401 | Aug 21, 2026 |
| Aug 20, 2026 | Bluestone Jeffrey | Director | open-market sale10b5-1 | 335 | $146.26 | $49K | 10,066 | Aug 21, 2026 |
| Aug 17, 2026 | Dickinson Andrew D | Chief Financial Officer | open-market sale10b5-1 | 3,000 | $138.36 | $415K | 165,646 | Aug 18, 2026 |
| Aug 17, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | option exercise | 23,110 | $66.64 | $2M | 144,344 | Aug 18, 2026 |
| Aug 17, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | option exercise | 1,890 | $72.34 | $137K | 146,234 | Aug 18, 2026 |
| Aug 17, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | open-market sale10b5-1 | 16,530 | $137.37 | $2M | 129,704 | Aug 18, 2026 |
| Aug 17, 2026 | Mercier Johanna | Chief Comm & Corp Aff Officer | open-market sale10b5-1 | 11,470 | $138.04 | $2M | 118,234 | Aug 18, 2026 |
| Aug 10, 2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | option exercise | 6,002 | — | — | 11,362 | Aug 11, 2026 |
| Aug 10, 2026 | Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | tax withholding | 2,908 | $133.06 | $387K | 8,454 | Aug 11, 2026 |
| Aug 3, 2026 | O'Day Daniel Patrick | Chairman & CEO, Director | open-market sale10b5-1 | 6,700 | $129.66 | $869K | 600,433 | Aug 4, 2026 |
| Aug 3, 2026 | O'Day Daniel Patrick | Chairman & CEO, Director | open-market sale10b5-1 | 7,700 | $130.80 | $1M | 592,733 | Aug 4, 2026 |
| Aug 3, 2026 | O'Day Daniel Patrick | Chairman & CEO, Director | open-market sale10b5-1 | 600 | $131.34 | $79K | 592,133 | Aug 4, 2026 |
| Jul 15, 2026 | Dickinson Andrew D | Chief Financial Officer | open-market sale10b5-1 | 3,000 | $129.93 | $390K | 168,646 | Jul 16, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| O'Day Daniel Patrick | Chairman & CEO, Director | Oct 1, 2026 | open-market sale | 569,683 | — | $53M (27) | 27 of 27 |
| Mercier Johanna | Chief Comm & Corp Aff Officer | Oct 15, 2026 | open-market sale | 113,684 | — | $19M (23) | 23 of 23 |
| Telman Deborah H | EVP, Corporate Affairs & GC | Nov 12, 2025 | option exercise | 60,857 | — | $7M (3) | 3 of 3 |
| Dickinson Andrew D | Chief Financial Officer | Oct 15, 2026 | open-market sale | 161,096 | — | $5M (12) | 12 of 12 |
| Welters Anthony | Director | Aug 26, 2026 | option exercise | 20,612 | — | $3M (4) | 4 of 4 |
| Bluestone Jeffrey | Director | Aug 20, 2026 | option exercise | 11,231 | — | $2M (7) | 6 of 7 |
| Kramer Kelly A. | Director | Nov 28, 2025 | open-market sale | 1,339 | — | $713K (2) | 2 of 2 |
| Parsey Merdad | Chief Medical Officer | Dec 10, 2024 | tax withholding | 82,850 | — | — | — |
| Berger Dietmar | Chief Medical Officer | Sep 10, 2026 | option exercise | 19,785 | — | — | — |
| Cain Wettan Keeley M | EVP Gen Counsel, Legal & Comp | Sep 10, 2026 | option exercise | 9,044 | — | — | — |
| Patterson Sandra | SVP, Controllership | Mar 10, 2025 | tax withholding | 39,453 | — | — | — |
| Manwani Harish | Director | Apr 30, 2026 | award | 15,239 | — | — | — |
| Wilfong Diane E. | Interim Corp Controller & CAO | Sep 10, 2025 | tax withholding | 46,259 | — | — | — |
| Burkhart Erin | SVP, Controllership | Sep 22, 2026 | option exercise | 2,223 | — | — | — |
| Barton Jacqueline K | Director | Apr 30, 2026 | award | 27,202 | — | — | — |
| Horning Sandra | Director | Apr 30, 2026 | award | 6,293 | — | — | — |
| Love Ted W | Director | Apr 30, 2026 | award | 5,484 | — | — | — |
| Rodriguez Javier | Director | Apr 30, 2026 | award | 13,364 | — | — | — |
| Gilead Sciences, INC. | 10% owner | May 26, 2026 | award | 5M | — | — | — |
Questions
Are Gilead Sciences Inc insiders buying or selling?
Over the twelve months to November 1, 2026, 7 insiders at Gilead Sciences Inc sold $88M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $88M. Only open-market purchases and sales are counted.
Who sold the most Gilead Sciences Inc stock in the last year?
O'Day Daniel Patrick (Chairman & CEO, Director) sold $53M in 27 open-market sales over the twelve months to November 1, 2026.
Do Gilead Sciences Inc executives sell under 10b5-1 plans?
77 of the 78 open-market sales in the last twelve months (99%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Gilead Sciences Inc
- Gilead Sciences Inc financial statements
- 1 tracked fund holding GILD
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.